Moberg Pharma AB (publ) (STO:MOB)

Market Cap	382.12M
Revenue (ttm)	12.35M
Net Income (ttm)	-254.73M
Shares Out	47.00M
EPS (ttm)	-5.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,319
Average Volume	103,901
Open	8.40
Previous Close	8.05
Day's Range	8.00 - 8.40
52-Week Range	6.34 - 32.50
Beta	0.77
RSI	38.24
Earnings Date	Aug 12, 2025

About Moberg Pharma AB

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 10
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MOB